2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID, (2R,5S,13AR)-
UNII RD7MNM79RD

Substance Identification & Data

This profile provides standardized clinical and technical data for 2,3,4,5,7,9,13,13a-octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxylic Acid, (2r,5s,13ar)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RD7MNM79RD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1616342-45-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RD7MNM79RD

CAS Registry Number

1616342-45-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID, (2R,5S,13AR)-

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C15H16N2O6

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

GARGTTZRFPGJSI-QXFUBDJGSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

90328049

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

O1[C@]2(N([C@]3(CC[C@@]1(C3)[H])[H])C(c4n(C2)cc(c(c4OC)=O)C(=O)O)=O)[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 2,3,4,5,7,9,13,13a-octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxylic Acid, (2r,5s,13ar)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.